Skip to content
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Oncology Qdata
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Oncology Qdata
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Press
Verana Health Delivers Powerful Update to RWD Bladder Cancer Database
May 21, 2026
Read More...
Verana Health Introduces Expanded Ovarian Cancer Dataset
May 19, 2026
Read More...
Verana Health Introduces World’s Largest Real-World Dataset for Prostate Cancer
April 30, 2026
Read More...
New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions
April 28, 2026
Read More...
New Study Shows Increasing Value of Real-World Data (RWD) in Clinical Trials
April 7, 2026
Read More...
Verana Health Enhances World Renowned RWD Ophthalmic Registry with Images
March 10, 2026
Read More...
Verana Health Introduces Industry First End-to-End Urologic-Oncology Datasets to Support Research
February 19, 2026
Read More...
Verana Health Named Growth and Innovation Leader in 2025 Frost Radar™ for Life Sciences Real-World Evidence Solutions
January 22, 2026
Read More...
Verana Health Enhances Site Explorer Tool to Expedite Urology Clinical Trials
January 15, 2026
Read More...
Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties
January 8, 2026
Read More...
1
2
3
…
25
Next »